EX-13.1 8 tm206812d1_ex13-1.htm EXHIBIT 13.1

Exhibit 13.1

 

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Annual Report on Form 20-F for the fiscal year ended December 31, 2019 of Itamar Medical Ltd. (the “Company”) as filed with the U.S. Securities and Exchange Commission on the date hereof (the “Report”) and pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, I, Gilad Glick, certify that, to the best of my knowledge:

 

  the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

 

  the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

 

/s/ Gilad Glick  
Date: April 3, 2020 Gilad Glick  
  President and Chief Executive Officer  
  (Principal Executive Officer)